Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir

NCT02945956 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

192

Enrollment

OTHER

Sponsor class

Conditions

Portal Hypertension

Interventions

DRUG: Entecavir
DRUG: Entecavir + Fuzheng Huayu

Sponsor

ShuGuang Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]